26
Participants
Start Date
July 1, 2021
Primary Completion Date
July 5, 2024
Study Completion Date
July 5, 2024
Sildenafil 50 mg
Sildenafil is a phosphodiesterase type-5 inhibitor, which augments/prolongs the naturally occurring nitric oxide mediated vasodilatory pathway. Sildenafil pill is over-encapsulated to be identical in appearance to the placebo intervention.
Placebo
Medical-grade placebo pill, over-encapsulated to be identical in appearance to the sildenafil intervention.
Clinical Physiology Laboratory, Edmonton
University of Alberta
OTHER